论文部分内容阅读
目的探讨绝经后妇女应用绝经激素治疗对体重指数的影响。方法对2013年10月—2014年10月在郑州大学第一附属医院妇科门诊就诊的绝经后妇女进行筛选,将其中有绝经激素治疗适应证并排除禁忌证和慎用情况的92例纳入研究,随机分为利维爱组和补佳乐组,每组各46例,利维爱组给予替勃龙1.25mg/天治疗,补佳乐组给予戊酸雌二醇1mg/天+地屈孕酮5mg/天治疗,比较两组治疗前和用药3个月、6个月、12个月体重指数(BMI)变化情况。结果两组妇女治疗前后BMI无明显变化,差异无统计学意义(P>0.05)。结论绝经后妇女应用绝经激素治疗短期内不会引起患者体重变化。
Objective To investigate the effect of postmenopausal hormone therapy on body mass index (BMI). Methods A total of 92 postmenopausal women with gynecological clinics in the First Affiliated Hospital of Zhengzhou University from October 2013 to October 2014 were enrolled in this study. 92 cases with menopausal hormone therapy indications, excluding contraindications and caution were included in the study. Randomly divided into levofloxacin group and nociceptive group, each group of 46 cases, levofloxacin group given tibolone 1.25mg / day treatment, nocturnal group given estradiol valerate 1mg / day + flexor pregnancy Ketone 5mg / day treatment, compared two groups before treatment and medication 3 months, 6 months, 12 months body mass index (BMI) changes. Results There was no significant difference in BMI between the two groups before and after treatment (P> 0.05). Conclusion Postmenopausal women using menopausal hormone therapy will not cause weight changes in patients in the short term.